Such findings provide evidence that CeD may potentially operate an enhanced HLA-DQ exosomal transportation mechanism compared to healthy CTLs, presumably for antigen presentation to T cells in addition to conventional MHC–TCR complex interaction. The gene discussed is HLA-C; the disease is cranioectodermal dysplasia.